| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M110.127019 |
| P8608 | Fatcat ID | release_qroen7dis5hhjkerfalhymnpva |
| P932 | PMC publication ID | 2934703 |
| P698 | PubMed publication ID | 20592020 |
| P50 | author | Artur Schmidtchen | Q88461456 |
| Martina Kalle | Q114138745 | ||
| Victoria Rydengård | Q114138751 | ||
| Katarina Lundqvist | Q114138777 | ||
| Barbara Albiger | Q114138787 | ||
| Martin Malmsten | Q58780071 | ||
| P2093 | author name string | Matthias Mörgelin | |
| Praveen Papareddy | |||
| Gopinath Kasetty | |||
| P2860 | cites work | Histidine-rich glycoprotein protects from systemic Candida infection | Q24313429 |
| Proteolytic inactivation of tissue factor pathway inhibitor by bacterial omptins | Q24658383 | ||
| Structural mechanism for heparin-binding of the third Kunitz domain of human tissue factor pathway inhibitor | Q27637118 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| Defensins: antimicrobial peptides of innate immunity | Q28204453 | ||
| Cathelicidins, multifunctional peptides of the innate immunity | Q28205494 | ||
| LL-37, the only human member of the cathelicidin family of antimicrobial peptides | Q28241675 | ||
| Tissue factor pathway inhibitor: structure, biology and involvement in disease | Q28279765 | ||
| Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14 | Q73436759 | ||
| A novel degradation pathway of tissue factor pathway inhibitor: incorporation into fibrin clot and degradation by thrombin | Q73686459 | ||
| Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity | Q77366940 | ||
| Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37 | Q77630845 | ||
| Identification of heparin/heparan sulfate interacting protein as a major broad-spectrum antimicrobial protein in lung and small intestine | Q80771027 | ||
| Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor | Q28284809 | ||
| Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 | ||
| Proteolysis of human thrombin generates novel host defense peptides | Q29871443 | ||
| Amphipathic, alpha-helical antimicrobial peptides | Q33994626 | ||
| Antimicrobial proteins and peptides in host defense | Q34223226 | ||
| Molecular diversity in gene-encoded, cationic antimicrobial polypeptides. | Q34595498 | ||
| What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses? | Q35143463 | ||
| The contact system--a novel branch of innate immunity generating antibacterial peptides | Q35191114 | ||
| Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock | Q35611991 | ||
| The relationship between peptide structure and antibacterial activity | Q35690395 | ||
| Anti-microbial peptides: from invertebrates to vertebrates. | Q35806874 | ||
| Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics | Q36126588 | ||
| Alpha-helical antimicrobial peptides--using a sequence template to guide structure-activity relationship studies | Q36469872 | ||
| Advances in antimicrobial peptide immunobiology | Q36493474 | ||
| The haemostatic role of tissue factor pathway inhibitor. | Q36977056 | ||
| Interaction between the coagulation and complement system | Q37331658 | ||
| Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells | Q37628594 | ||
| Activation of the complement system generates antibacterial peptides | Q37695583 | ||
| Alternatively spliced isoforms of tissue factor pathway inhibitor | Q37696775 | ||
| CAP37, a neutrophil-derived multifunctional inflammatory mediator | Q40550510 | ||
| Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers | Q40658136 | ||
| The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor | Q40910806 | ||
| Composition effect on peptide interaction with lipids and bacteria: variants of C3a peptide CNY21. | Q41047319 | ||
| Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. | Q41628125 | ||
| Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. | Q43002265 | ||
| Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism | Q43181764 | ||
| Antimicrobial activities of heparin-binding peptides | Q44629787 | ||
| Ultrasensitive assays for endogenous antimicrobial polypeptides | Q45416239 | ||
| Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures | Q46357600 | ||
| Comparison of the helix-coil transition of a titrating polypeptide in aqueous solutions and at the air-water interface | Q46505055 | ||
| Domain 5 of high molecular weight kininogen is antibacterial | Q46642869 | ||
| Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity | Q47247959 | ||
| Heparin binding protein is increased in chronic leg ulcer fluid and released from granulocytes by secreted products of Pseudomonas aeruginosa. | Q51642205 | ||
| The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes. | Q53509908 | ||
| Antimicrobial peptides derived from growth factors. | Q54442631 | ||
| Low temperature embedding with Lowicryl resins: two new formulations and some applications | Q69928849 | ||
| Computed circular dichroism spectra for the evaluation of protein conformation | Q71225133 | ||
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 28387-28398 | |
| P577 | publication date | 2010-06-30 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules | |
| P478 | volume | 285 |
| Q53712921 | A new cryptic cationic antimicrobial peptide from human apolipoprotein E with antibacterial activity and immunomodulatory effects on human cells. |
| Q33927961 | A peptide of heparin cofactor II inhibits endotoxin-mediated shock and invasive Pseudomonas aeruginosa infection. |
| Q33737867 | Aggregation of thrombin-derived C-terminal fragments as a previously undisclosed host defense mechanism. |
| Q37881747 | Alternatively spliced tissue factor pathway inhibitor: functional implications |
| Q54267933 | An ecoimmunological approach to study evolutionary and ancient links between coagulation, complement and Innate immunity. |
| Q38447222 | Antifungal activities of peptides derived from domain 5 of high-molecular-weight kininogen |
| Q36439097 | Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli |
| Q54344153 | Antimicrobial activity of peptides derived from human ß-amyloid precursor protein. |
| Q41747279 | Antimicrobial effects of helix D-derived peptides of human antithrombin III |
| Q37954721 | Antimicrobial peptides: key components of the innate immune system |
| Q35222585 | Discovery of modulators of HIV-1 infection from the human peptidome |
| Q36254797 | Effect of Regular Exercise on Inflammation Induced by Drug-resistant Staphylococcus aureus 3089 in ICR mice |
| Q55123953 | Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia. |
| Q50980605 | Endothelial cell-anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in mice. |
| Q35636201 | Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia |
| Q28476835 | Highly selective end-tagged antimicrobial peptides derived from PRELP |
| Q27331817 | Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis |
| Q26741309 | Multiple Functions of the New Cytokine-Based Antimicrobial Peptide Thymic Stromal Lymphopoietin (TSLP) |
| Q35071276 | Neutrophil serine proteases in antibacterial defense |
| Q36914757 | Proteolytic activation transforms heparin cofactor II into a host defense molecule |
| Q58750549 | TFPI-2 Protects Against Gram-Negative Bacterial Infection |
| Q35067228 | The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis. |
| Q89601715 | Thrombin-derived C-terminal fragments aggregate and scavenge bacteria and their proinflammatory products |
| Q43878141 | Thymic stromal lymphopoietin exerts antimicrobial activities |
| Q34541158 | Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activity |
| Q37971520 | Tissue factor pathway inhibitor: structure-function |
| Q64052051 | Transcriptomic analysis reveals insights into deep-sea adaptations of the dominant species, Shinkaia crosnieri (Crustacea: Decapoda: Anomura), inhabiting both hydrothermal vents and cold seeps |
| Q28597180 | Vertebrate TFPI-2 C-terminal peptides exert therapeutic applications against Gram-negative infections |
Search more.